Hindsight bias in investment decisions
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Hindsight bias in investment decisions
-
Lu par :
-
De :
À propos de ce contenu audio
In this episode, I discuss my rationale for investing in five different securities in the Healthcare / Pharma, Tech / Data, Fintech / VC sectors.
- EXASOL AG (Germany)
- German Startups Group (Germany)
- Sensyne Health (UK)
- Vivoryon Therapeutics (Germany)
- Amigo Holdings(UK)
I also discuss the performance of each of these five securities. They returned between -16% and +125% in the period I have held them (about two weeks). I then go on to discuss the concept of Hindsight bias and how it affects investment decisions, as well as recommendations for coping with hindsight bias as an investor. Feel free to reach out to me on:
- LinkedIn (Nosakhare M. ugiagbe)
- Twitter (@NosaMUgiagbe)
- Instagram (Nosa_ugiagbe)
- Blog / Website (https://www.nosaugiagbe.com/)
Aucun commentaire pour le moment
